EORTC 2016

November 29 - Dec 2, 2016 in Munich, Germany

World CDx Boston 2016

October 18-21, 2016 in Boston, Massachusetts

ESMO 2016

October 7-11, 2016 in Copenhagen, Denmark

ASCO Annual Meeting 2016

June 3-7, 2016 in Chicago, Illinois

AUA 2016

May 6-10, 2016 in San Diego, California

AACR Annual Meeting 2016

April 16-20, 2016 in New Orleans, Lousiana

Molecular Medicine Tri-Conference 2016

2016 Molecular Med TRI-CON San Francisco, CA Murali Prahalad, Ph.D., president and CEO, is scheduled to present in the Circulating Tumor Cell Program at Molecular Med TRI CON 2016, which is taking place at the Moscone North Convention Center, in San Francisco, CA on March 7, 2016.

Personalized Medicine World Conference 2016

PMWC Silicon Valley - 2016 Murali Prahalad, Ph.D., president and CEO, will chair a session titled "Liquid Biopsy - Using the Right Tool for the Right Job" at PMWC Silicon Valley 2016

World CDx - Boston 2015

Murali Prahalad, Ph.D., president and CEO, will give a presentation entitled "Matching the Spectrum of Cellular Heterogeneity to the Spectrum of Therapeutic Response in Cancer" at World Cdx Boston 2015

ASCO GU 2015

Epic’s collaborators are presenting three studies at the 2015 ASCO Genitourinary Cancers Symposium held in Orlando, Fla., that demonstrate how the Epic Sciences no cell left behind™ platform could be used as a blood test for certain types of metastatic prostate and bladder cancers — liquid biopsies to predict which patients will best respond to certain therapies before they are treated.